Created to promote efficient, fast, and predictable manufacturing of high-quality recombinant protein drugs and vaccines, the AltHost Consortium intends to realize next-generation agile solutions for biologic manufacturing. The Consortium comprises Amgen, Biogen, CSIR, Mott Corporation, Novonesis, Pfizer Inc., Sanofi, Sartorius, Serum Institute of India, Sunflower Therapeutics, TurtleTree, 21st.BIO, and the Bill & Melinda Gates Foundation.
Through the leadership of Prof. J. Christopher Love, they work together to further experimentation, reduce research and development costs, flexibly address industry needs, improve product quality, and grow volumetric productivity of high-quality drugs and vaccines.